Revenio Group Corporation | Stock Exchange Release | October 30, 2025 at 09:05:00 EET
Revenio Group Corporation will publish the following financial reports in 2026:
- Financial Statements Bulletin for the year 2025 on Wednesday, February 11, 2026
- Annual reporting package 2025 will be published at the latest during week 13 in 2026
- Interim report 1-3/2026 on Tuesday, April 28, 2026
- Half-year financial report 1-6/2026 on Thursday, August 6, 2026
- Interim report 1-9/2026 on Thursday, October 29, 2026
The financial statements bulletin, half-year report, and interim reports will be published at approximately 9.00 am Finnish time on the above dates.
The Annual General Meeting is planned to be held on Thursday, April 15, 2026. The Board of Directors will convene the meeting.
A shareholder who wishes to include an item on the agenda of the Annual General Meeting shall submit the request in writing to the company's Board of Directors by February 23, 2026. Such requests, including the reasoning or a resolution proposal, can be submitted to the address: Revenio Group Corporation / Board of Directors, Härkähaankuja 7, FI-01730 Vantaa, Finland.
For further information, please contact
Robin Pulkkinen, CFO, tel. +358 50 505 9932
robin.pulkkinen@revenio.fi
Distribution
Nasdaq Helsinki
Financial Supervisory Authority (FIN-FSA)
Key media
www.reveniogroup.fi/en
Revenio Group in brief
Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand.
In 2024, the Group’s net sales totaled EUR 103.5 million, with an operating profit of EUR 25.0 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.